Literature DB >> 12126280

Preventing diabetes-related morbidity and mortality in the primary care setting.

Samuel Dagogo-Jack1.   

Abstract

Diabetes is the leading cause of blindness, end-stage renal failure, non-traumatic limb amputations, and cardiovascular morbidity and mortality. The vast majority of patients with diabetes receive routine care from primary care providers who are not endocrinologists. Primary care providers, including internists, family practice physicians, and physician extenders with advanced skills, face the important task of implementing standards of care recommendations for persons with diabetes. These recommendations draw upon an emerging body of compelling evidence regarding the prevention and management diabetes and its complications. The challenge of diabetes must be tackled on three fronts: Primary prevention, secondary prevention (of diabetes complications), and tertiary prevention (of morbidity and mortality from established complications). There is now abundant evidence that type 2 diabetes, which accounts for greater than 90% of diabetes world-wide, is preventable. Moreover, the complications of diabetes are preventable by a policy of tight glycemic control and comprehensive risk reduction. Even after complications have set in, intensive glucose control dramatically reduces the risk of progression of complications. The challenge, therefore, is the identification of strategies that enable translation of existing scientific data to pragmatic benefits. This article proposes 10 strategies for preventing or reducing diabetes-related morbidity and mortality at the primary care level. These strategies include provider education; patient empowerment through promotion of lifestyle and self-care practices; surveillance for microvascular complications; cardiovascular risk reduction; efficient use of medications; goal setting; and stratification of patients and triaging of those with poor glycemic control for more intensive management.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12126280      PMCID: PMC2594314     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  24 in total

Review 1.  Management of type 2 diabetes mellitus.

Authors:  M B Murphy; A E Kitabchi
Journal:  Tenn Med       Date:  2000-11

2.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

3.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

4.  Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study.

Authors:  F L Brancati; W H Kao; A R Folsom; R L Watson; M Szklo
Journal:  JAMA       Date:  2000-05-03       Impact factor: 56.272

5.  Diabetes trends in the U.S.: 1990-1998.

Authors:  A H Mokdad; E S Ford; B A Bowman; D E Nelson; M M Engelgau; F Vinicor; J S Marks
Journal:  Diabetes Care       Date:  2000-09       Impact factor: 19.112

6.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

7.  Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels.

Authors:  S F Jencks; T Cuerdon; D R Burwen; B Fleming; P M Houck; A E Kussmaul; D S Nilasena; D L Ordin; D R Arday
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

8.  Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes.

Authors:  M I Harris
Journal:  Diabetes Care       Date:  2001-03       Impact factor: 19.112

9.  Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics.

Authors:  P J Boyle; N S Schwartz; S D Shah; W E Clutter; P E Cryer
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

10.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Authors:  Y Ohkubo; H Kishikawa; E Araki; T Miyata; S Isami; S Motoyoshi; Y Kojima; N Furuyoshi; M Shichiri
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

View more
  10 in total

1.  JNMA article helps doctors treat diabetic patients.

Authors:  M R Hayden
Journal:  J Natl Med Assoc       Date:  2002-12       Impact factor: 1.798

Review 2.  Physical activity-induced remodeling of vasculature in skeletal muscle: role in treatment of type 2 diabetes.

Authors:  M Harold Laughlin
Journal:  J Appl Physiol (1985)       Date:  2015-10-15

Review 3.  A systematic review of interactive computer-assisted technology in diabetes care. Interactive information technology in diabetes care.

Authors:  Chandra L Jackson; Shari Bolen; Frederick L Brancati; Marian L Batts-Turner; Tiffany L Gary
Journal:  J Gen Intern Med       Date:  2005-12-22       Impact factor: 5.128

Review 4.  Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.

Authors:  Ben Brannick; Sam Dagogo-Jack
Journal:  Endocrinol Metab Clin North Am       Date:  2018-03       Impact factor: 4.741

Review 5.  Endurance, interval sprint, and resistance exercise training: impact on microvascular dysfunction in type 2 diabetes.

Authors:  T Dylan Olver; M Harold Laughlin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-25       Impact factor: 4.733

6.  Targeting diabetes preventive care programs: insights from the 2001 Behavioral Risk Factor Surveillance Survey.

Authors:  Martha M Phillips
Journal:  Prev Chronic Dis       Date:  2003-12-15       Impact factor: 2.830

7.  EMPOWER-support of patient empowerment by an intelligent self-management pathway for patients: study protocol.

Authors:  Sarah Mantwill; Maddalena Fiordelli; Ramona Ludolph; Peter J Schulz
Journal:  BMC Med Inform Decis Mak       Date:  2015-03-20       Impact factor: 2.796

8.  Effect of Lupin-Enriched Biscuits as Substitute Mid-Meal Snacks on Post-Prandial Interstitial Glucose Excursions in Post-Surgical Hospital Patients with Type 2 Diabetes.

Authors:  Sophie Skalkos; George Moschonis; Colleen J Thomas; Joanna McMillan; Antigone Kouris-Blazos
Journal:  Nutrients       Date:  2020-04-27       Impact factor: 5.717

9.  Cardiovascular outcomes of antidiabetes medications by race/ethnicity: A systematic review and meta-analysis.

Authors:  Xiaoling Cai; Chu Lin; Wenjia Yang; Sam Dagogo-Jack; Linong Ji
Journal:  J Diabetes Complications       Date:  2021-06-27       Impact factor: 3.219

10.  Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.

Authors:  Melvin R Hayden; Suresh C Tyagi
Journal:  Cardiovasc Diabetol       Date:  2002-09-27       Impact factor: 9.951

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.